Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles-Reference-Cited by-同舟云学术

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

Published:1992-08 Issue:3 Volume:10 Page:191-199
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Kattan Joseph,Droz Jean-Pierre,Couvreur Patrick,Marino Jean-Pierre,Boutan-Laroze Arnaud,Rougier Philippe,Brault Philippe,Vranckx Henri,Grognet Jean-Marc,Morge Xavier,Sancho-Garnier H�l�ne

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00877245.pdf

Reference18 articles.

1. O'Bryan, R, Luce J, Talley R, Gottlieb J, Baker L, Bonadonna G: Phase II evaluation of adriamycin in human neoplasia. Cancer 32:1?8, 1973

2. O'Bryan R, Baker L, Gottlieb J, Rivkin S, Balcerzak S, Grumet G, Salmon S, Moon T, Hoogstraten B: Dose response evaluation of adriamycin in human neoplasia. Cancer 39:1940?1948, 1977

3. Bristow M, Lopez M, Mason J, Billingham M, Winchester M: Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer 50:32?41, 1982

4. Couvreur P, Roblot-Treupel L, Poupon M, Brasseur F, Puisieux F: Nanoparticles as microcarriers for anticancer drugs. Ad Drug Delivery Rev 5:209?230, 1990

5. Storm G, Van Hoesel O, Groot G, Kop W, Steerenberg P, Hillen F: A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus continuous infusion or entrapped in liposomes in the Lou/M Wsl rat. Cancer Chemother Pharmacol 24:341?348, 1989

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the MRI contrast and hyperthermic properties of magnetic nanoflowers by modulating magnetisation dynamics using poly(butyl cyanoacrylate) shells: Towards multi-functional clinical carriers;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-08

2. Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines;ACS Nano;2023-03-16

3. Novel gas‐based nanomedicines for cancer therapy;VIEW;2022-01

4. Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy;Expert Review of Anticancer Therapy;2021-11-01

5. Vinyl Polymer-based technologies towards the efficient delivery of chemotherapeutic drugs;Progress in Polymer Science;2021-10